Cardiac AI Funding: Top 10 Companies & What It Means for Investors
The landscape of cardiovascular artificial intelligence (AI) is rapidly evolving, marked by a significant influx of capital that…
Cardiac AI: US Dominance, Israel’s Outsized Innovation
The landscape of cardiac Artificial Intelligence (AI) is rapidly evolving, a dynamic arena where innovation promises to redefine…
JAHA Publication: The Gold Standard for Cardiac AI Investment
The proliferation of artificial intelligence in healthcare has ushered in an era of unprecedented innovation, particularly within cardiology.…
HeartFlow’s Billion Dollar IPO: Clinical Evidence Driving Cardiac AI Valuation
The recent trajectory of HeartFlow, particularly its substantial capital raise and a deep evidentiary base, compels a rigorous…
HeartFlow’s 625+ Papers: The Billion Dollar Evidence Moat
The valuation of AI in healthcare often orbits a singular, undeniable truth: clinical evidence is the ultimate de-risking…